SG10201804944XA - Use of tenecteplase for treating acute ischemic stroke - Google Patents

Use of tenecteplase for treating acute ischemic stroke

Info

Publication number
SG10201804944XA
SG10201804944XA SG10201804944XA SG10201804944XA SG10201804944XA SG 10201804944X A SG10201804944X A SG 10201804944XA SG 10201804944X A SG10201804944X A SG 10201804944XA SG 10201804944X A SG10201804944X A SG 10201804944XA SG 10201804944X A SG10201804944X A SG 10201804944XA
Authority
SG
Singapore
Prior art keywords
tenecteplase
ischemic stroke
treating acute
acute ischemic
treating
Prior art date
Application number
SG10201804944XA
Inventor
Peter Kuebler
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38835003&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG10201804944X(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of SG10201804944XA publication Critical patent/SG10201804944XA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG10201804944XA 2006-08-29 2007-08-01 Use of tenecteplase for treating acute ischemic stroke SG10201804944XA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82386806P 2006-08-29 2006-08-29

Publications (1)

Publication Number Publication Date
SG10201804944XA true SG10201804944XA (en) 2018-07-30

Family

ID=38835003

Family Applications (3)

Application Number Title Priority Date Filing Date
SG2011062213A SG174753A1 (en) 2006-08-29 2007-08-01 Use of tenecteplase for treating acute ischemic stroke
SG10201501498VA SG10201501498VA (en) 2006-08-29 2007-08-01 Use of tenecteplase for treating acute ischemic stroke
SG10201804944XA SG10201804944XA (en) 2006-08-29 2007-08-01 Use of tenecteplase for treating acute ischemic stroke

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SG2011062213A SG174753A1 (en) 2006-08-29 2007-08-01 Use of tenecteplase for treating acute ischemic stroke
SG10201501498VA SG10201501498VA (en) 2006-08-29 2007-08-01 Use of tenecteplase for treating acute ischemic stroke

Country Status (22)

Country Link
US (2) US20080107641A1 (en)
EP (1) EP2056856B1 (en)
JP (1) JP5785687B2 (en)
KR (1) KR20090045405A (en)
CN (1) CN101505785A (en)
AU (1) AU2007290277B2 (en)
BR (1) BRPI0716143A2 (en)
CA (1) CA2661012C (en)
CO (1) CO6150188A2 (en)
EA (1) EA015573B1 (en)
EC (1) ECSP099178A (en)
HK (1) HK1131054A1 (en)
IL (2) IL196987A (en)
MX (1) MX2009001918A (en)
MY (1) MY163119A (en)
NO (1) NO342302B1 (en)
NZ (1) NZ574767A (en)
SG (3) SG174753A1 (en)
TW (1) TWI439282B (en)
UA (1) UA97486C2 (en)
WO (1) WO2008027687A2 (en)
ZA (1) ZA200900957B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
UA95903C2 (en) 2005-02-24 2011-09-26 Дифьюжен Фармасьютикалз Ллк Trans carotenoids, their synthesis, formulation and uses
US20080107641A1 (en) 2006-08-29 2008-05-08 Genentech, Inc. Method of treating stroke with thrombolytic agent
JP2010524855A (en) 2007-04-13 2010-07-22 ディフュージョン・ファーマシューティカルズ・エルエルシー Use of bipolar trans carotenoids as and in the pretreatment of peripheral vascular disease
US9034007B2 (en) 2007-09-21 2015-05-19 Insera Therapeutics, Inc. Distal embolic protection devices with a variable thickness microguidewire and methods for their use
JP2012513812A (en) * 2008-12-24 2012-06-21 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ System, method and apparatus for cardiac intervention with MR stroke detection and treatment
EP2445339B1 (en) 2009-06-22 2019-08-07 Diffusion Pharmaceuticals LLC Diffusion enhancing compound and its use with a thrombolytic
US10555915B2 (en) 2009-08-24 2020-02-11 Hough Ear Institute Methods for treating acute acoustic trauma
CN105287473A (en) 2010-06-02 2016-02-03 扩散药品有限公司 Oral formulations of bipolar trans carotenoids and uses thereof
ES2687850T3 (en) * 2010-12-23 2018-10-29 Gennova Biopharmaceuticals Ltd. Pharmaceutical compositions of tenecteplase
WO2014062888A1 (en) * 2012-10-18 2014-04-24 University Of South Florida Compositions and methods for treating stroke
US8679150B1 (en) 2013-03-15 2014-03-25 Insera Therapeutics, Inc. Shape-set textile structure based mechanical thrombectomy methods
SG11201507173QA (en) 2013-03-15 2015-10-29 Insera Therapeutics Inc Vascular treatment devices and methods
US8715314B1 (en) 2013-03-15 2014-05-06 Insera Therapeutics, Inc. Vascular treatment measurement methods
US8690907B1 (en) 2013-03-15 2014-04-08 Insera Therapeutics, Inc. Vascular treatment methods
WO2015023830A1 (en) 2013-08-14 2015-02-19 Stc.Unm Treatment and prevention of stroke and other neurological disorders
DK3209767T3 (en) * 2014-10-21 2020-11-02 Gennova Biopharmaceuticals Ltd PREVIOUS PURIFICATION PROCEDURE FOR INSULATION AND COMMERCIAL MANUFACTURE OF RECOMBINANT TNK-TPA (TENECTE PLASE)
CN108697423A (en) 2016-02-16 2018-10-23 伊瑟拉医疗公司 The part flow arrangement of suction unit and anchoring
KR20230014850A (en) 2016-03-24 2023-01-30 디퓨젼 파마슈티컬즈 엘엘씨 Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer
EP4272818A3 (en) * 2017-01-24 2024-02-14 Boston Scientific Scimed, Inc. Thrombolytic agent for the treatment of thromboembolism
WO2018210860A1 (en) * 2017-05-16 2018-11-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of acute ischemic stroke
US10426424B2 (en) 2017-11-21 2019-10-01 General Electric Company System and method for generating and performing imaging protocol simulations
US20230068460A1 (en) * 2020-02-04 2023-03-02 The Regents Of The University Of Colorado, A Body Corporate Prophylactic uses of annexin a2

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
JP3559559B2 (en) 1992-06-03 2004-09-02 ジェネンテク，インコーポレイテッド Tissue plasminogen activator glycosylation variants with enhanced therapeutic properties
JP2002173447A (en) * 2000-09-29 2002-06-21 Yamanouchi Pharmaceut Co Ltd Pharmaceutical composition for treatment of cerebral embolism
US7084118B2 (en) * 2002-02-22 2006-08-01 Genentech, Inc. Combination treatment with t-PA variant and low molecular weight heparin
US20030180282A1 (en) * 2002-03-25 2003-09-25 Victor Serebruany Method of treatment of thrombotic events
US20070014779A1 (en) * 2002-11-14 2007-01-18 Genentech, Inc. Plasminogen activator variant formulations
WO2006094120A2 (en) * 2005-03-02 2006-09-08 The Regents Of The University Of California Treatment for embolic stroke
US20080107641A1 (en) 2006-08-29 2008-05-08 Genentech, Inc. Method of treating stroke with thrombolytic agent

Also Published As

Publication number Publication date
SG10201501498VA (en) 2015-04-29
HK1131054A1 (en) 2010-01-15
BRPI0716143A2 (en) 2013-11-26
TWI439282B (en) 2014-06-01
WO2008027687A2 (en) 2008-03-06
NO20091296L (en) 2009-05-28
JP2010502629A (en) 2010-01-28
CA2661012C (en) 2019-03-19
EP2056856A2 (en) 2009-05-13
ZA200900957B (en) 2010-05-26
IL196987A0 (en) 2011-08-01
JP5785687B2 (en) 2015-09-30
UA97486C2 (en) 2012-02-27
KR20090045405A (en) 2009-05-07
ECSP099178A (en) 2009-06-30
IL196987A (en) 2016-10-31
EA200970237A1 (en) 2009-08-28
MY163119A (en) 2017-08-15
AU2007290277B2 (en) 2013-04-11
WO2008027687A3 (en) 2008-05-22
NO342302B1 (en) 2018-04-30
IL248176A0 (en) 2016-11-30
CO6150188A2 (en) 2010-04-20
EA015573B1 (en) 2011-10-31
EP2056856B1 (en) 2015-01-14
NZ574767A (en) 2012-02-24
SG174753A1 (en) 2011-10-28
MX2009001918A (en) 2009-03-06
TW200817033A (en) 2008-04-16
US9023346B2 (en) 2015-05-05
US20080107641A1 (en) 2008-05-08
CA2661012A1 (en) 2008-03-06
AU2007290277A1 (en) 2008-03-06
CN101505785A (en) 2009-08-12
US20120164157A1 (en) 2012-06-28

Similar Documents

Publication Publication Date Title
SG10201501498VA (en) Use of tenecteplase for treating acute ischemic stroke
IL194113A (en) Combinations of agents for treatment of stroke
EP2034830A4 (en) Methods of treating stroke
IL193460A0 (en) Compounds and methods for treatment of stroke
ZA201004859B (en) Use of a gamma-secretase inhibitor for treating cancer
EP1996182A4 (en) Cancer treatment with gamma-secretase inhibitors
IL193639A0 (en) Collagenase for treating cellulite
EP2264308A4 (en) Plasma device using cylinder head
EP2034984A4 (en) Method of treating atrophic vaginitis
EP2047976A4 (en) Steel plate-reinforcing material of type applying vibration-damping performance to steel plate
EP2325529A4 (en) Cylinder head gasket
GB2457583B (en) Paint-metering cylinder
GB0815766D0 (en) Rotary piston and cylinder devices
EP2078522A4 (en) Composition for treating allergy
EP2131030A4 (en) Cylinder block
IL212212A0 (en) Compound useful for treating cellulite
EP2249765A4 (en) Dapsone to treat rosascea
GB2453625B (en) Keys for cylinder assemblies
EP2306051A4 (en) Cylinder head gasket
ZA200807221B (en) Collagenase for treating cellulite
HK1119755A1 (en) Brake cylinder
ZA200900871B (en) Pressure cylinder
IL201328A0 (en) Cylinder lock
TWI368170B (en) Interruption-based concurrent profiling method
GB0817784D0 (en) Hydraulic cylinder and related arrangements